Report cover image

50 Key Biopharmaceutical and Biotechnology Companies

Publisher Kalorama Information
Published Dec 12, 2017
Length 201 Pages
SKU # KLI15550511

Description

50 Key Biopharmaceutical and Biotechnology Companies

Biopharmaceutical companies bring to market products that hold great promise for treating some of the most intractable medical conditions such as cancer and autoimmune disease. Biotech opportunities largely mirror those in the pharmaceutical industry. The key difference is that biotech firms are much more focused on research because they are still developing their initial products.

50 Key Biopharmaceutical and Biotechnology Companies is a comprehensive look at the top 50 companies that are shaping the biotherapeutics market in 2017 and beyond. The top 50 companies in this report were chosen for a variety of reasons, including sales of marketed biopharmaceutical products, innovation in biotherapeutics, and unique additions to the market, either marketed products or products in development.

50 Key Biopharmaceutical and Biotechnology Companies profiles the market leaders in-depth, presenting detailed information about each company, including:
  • a Corporate Summary
  • Selected Biopharmaceutical Products
  • Biopharmaceuticals in Development
  • Selected Corporate Developments
  • Company Financials
  • Regional Revenue Breakdown by Percentage (%)
This report includes profiles of large traditional pharma powerhouses such as Pfizer, Novartis, Roche, Merck, GSK, Bristol-Myers Squibb, Bayer, and others; but it also includes smaller niche companies such as Genmab, Seattle Genetics, etc. In addition, it includes leading biopharmaceuticals such as Amgen and Biogen, and leading biotech companies such as Qiagen, Alexion, Agilent, Waters Co and others.

Table of Contents

201 Pages
    • Introduction
    • Scope and Methodology
    • Market Summary
    • Biopharmaceuticals and Biotherapeutics
    • Regulations for Biopharmaceuticals
    • AbbVie
    • Agilent Technologies Inc.
    • Alexion Pharmaceuticals Inc
    • Allergan plc
    • Ambry Genetics
    • Amgen, Inc
    • AstraZeneca plc
    • Bayer AG
    • Berry Genomics Co Ltd.
    • Biogen
    • BioMarin Pharmaceutical Inc
    • Bristol Myers Squibb
    • Celgene
    • CRISPR Therapeutics AG
    • CSL Behring
    • Dr. Reddy's Laboratories Limited
    • Eli Lilly & Co
    • Enzo Biochem, Inc
    • Evotec AG
    • Exelixis
    • Genmab
    • Gilead Sciences
    • GlaxoSmithKline
    • Grifols International S.A.
    • Guardant Health
    • llumina
    • Incyte Corporation
    • Johnson & Johnson
    • Merck & Co, Inc.
    • Mylan
    • Myriad Genetics
    • Novartis International AG
    • Novo Nordisk A/S
    • Organogenesis
    • Oxford Nanopore Technologies
    • Perkin Elmer, Inc
    • Pfizer
    • Precision BioSciences Inc
    • QIAGEN N.V.
    • Regeneron Pharmaceuticals
    • Roche Ltd.
    • Sanofi
    • Seattle Genetics, Inc
    • Shire
    • Takeda
    • Teva Pharmaceutical Industries, Ltd.
    • Thermo Fisher Scientific, Inc
    • UCB S.A.
    • United Therapeutics Corporation
    • Waters Corporation

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us